Effects of muscarinic ganglionic stimulation and blockade upon ganglion responses to DMPP and nicotine.
D000818:Animals; D001285:Atropine / Q000494:pharmacology; D001794:Blood Pressure / Q000187:drug effects; D003864:Depression, Chemical; D004246:Dimethylphenylpiperazinium Iodide / Q000008:administration & dosage / Q000494:pharmacology; D004285:Dogs; D004338:Drug Combinations; D005725:Ganglia, Autonomic / Q000187:drug effects* / Q000502:physiology; D005731:Ganglionic Stimulants / Q000494:pharmacology*; D006339:Heart Rate / Q000187:drug effects; D006584:Hexamethonium Compounds / Q000494:pharmacology; D008297:Male; D009119:Muscle Contraction / Q000187:drug effects; D009388:Neostigmine / Q000494:pharmacology; D009538:Nicotine / Q000494:pharmacology*; D009638:Norepinephrine / Q000494:pharmacology*; D010879:Piperazines / Q000494:pharmacology*; D013233:Stellate Ganglion / Q000187:drug effects; D013268:Stimulation, Chemical; D009435:Synaptic Transmission / Q000187:drug effects
D004338:Drug Combinations; D005731:Ganglionic Stimulants; D006584:Hexamethonium Compounds; D010879:Piperazines; D009388:Neostigmine; D004246:Dimethylphenylpiperazinium Iodide; D009538:Nicotine; D001285:Atropine; D009638:Norepinephrine